Equip F
Equip F
Authorised
- Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated
- Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated
- Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated
Product identification
Medicine name:
Equip F
Active substance:
- Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated
- Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated
- Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated
Target species:
-
Horse
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated11.00haemagglutinating units1.00Dose
-
Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated22.00haemagglutinating units1.00Dose
-
Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated1.54haemagglutinating units1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Horse
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI05AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Type I glass syringe closed with bromobutyl rubber plunger stopper and tip cap.Packaging: Box of 10 single dose prefilled syringes with needles.
- Type I glass vial with chlorobutyl rubber stopper and aluminium overseal.Packaging: Box of 10 single dose vials. Each box contains ten sterile disposable 2ml syringes and 10 sterile needles.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10387/029/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 8/04/2022
How useful was this page?: